Alcon Sues Generics Maker Over Nasal Spray Patent

Law360, New York (October 17, 2011, 7:00 PM EDT) -- Alcon Pharmaceuticals Ltd. filed a patent infringement suit against Perrigo Co. in Texas on Friday in an effort to keep the generic-drug company from developing its own version of seasonal allergy relief nasal spray Patanase.

Alcon, a subsidiary of Novartis AG, claims Perrigo’s abbreviated new drug application submitted to the U.S. Food and Drug Administration for approval to market a version of olopatadine hydrochloride solution — the generic form of Patanase — infringes its patent.

“The manufacture, … sale and/or importation of Perrigo’s ANDA product would...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.